Current clinical evidence-based guidelines are based on disease-specific goals and intended outcomes. These guidelines may not be relevant for patients with Multiple Chronic Conditions (MCC) – the use of guidelines for this patient population may lead to inefficient care delivery that imped shared decision making between the patient and health care providers. Comparative effectiveness research (CER) is considered the number one solution for generating an evidence base to inform MCC care. CER is defined as the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat, and monitor health conditions in ‘real-time and real-world’ settings – and, reflects the needs of a specific patient population. CER data is used by clinicians, patients, policymakers and health plans to discern what is in the best interest for the patient.

The Recovery Act of 2009, provided $1.1 Billion dollars for patient-centered research also known as CER. $400 million to the National Institutes of Health, $400 million to the US Department of Health and Human Services and $300 to the Agency for Healthcare Research and Quality. This is another massive change directed through the Affordable Care Act. Health care professionals will be expected to embrace and utilize CER data to better inform the patient, improve patient-centered outcomes and reduce the costly care of patients with MCCs.

Learn more about how CER will be used in drug development, reimbursement and improved care for the largest and fastest growing US patient population. Attend the Health Policy and Clinical Practice Conference, March 26-28th, Savannah GA. Learn from dynamic Health Policy Leaders. Network with interdisciplinary professionals and be prepared for the changes from the Affordable Care Act.

Agency for Healthcare Research and Quality, 2010
National Institutes of Health, 2012
Patient-Centered Outcomes Research Institute, 2012